Stock Events

Stock Events

Stimcell Energetics 

$0.3489
0
+$0.06+20.31% Wednesday 13:30

Statistics

Day High
0.3489
Day Low
0.3489
52W High
0.6399
52W Low
0.25
Volume
-
Avg. Volume
-
Mkt Cap
7.29M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29JulExpected
Q1 2026
Next
-0.01
-0.01
-0
0
Expected EPS
-0.01
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-1.13MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow STME. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Dexcom
DXCM
Mkt Cap28.45B
Dexcom, Inc. specializes in glucose monitoring systems, competing in the medical device sector focused on diabetes management, similar to Cell MedX's focus.
Tandem Diabetes Care
TNDM
Mkt Cap1.18B
Tandem Diabetes Care, Inc. provides innovative insulin delivery systems, directly competing in the diabetes care market where Cell MedX operates.
Insulet
PODD
Mkt Cap10.04B
Insulet Corporation manufactures insulin pump technology, aligning with diabetes management solutions, a field relevant to Cell MedX's interests.
Abbott Laboratories
ABT
Mkt Cap149.1B
Abbott Laboratories offers a broad range of medical devices including glucose monitoring systems, competing in the same healthcare segment as Cell MedX.
Medtronic
MDT
Mkt Cap94.76B
Medtronic plc provides medical technologies, services, and solutions including diabetes management products, directly competing with Cell MedX's offerings.
Senseonics
SENS
Mkt Cap354.46M
Senseonics Holdings, Inc. focuses on the development of glucose monitoring systems, which is a direct competition to Cell MedX's diabetes-related technologies.
Novo Nordisk
NVO
Mkt Cap201.95B
Novo Nordisk A/S, a global healthcare company, focuses on diabetes care products, competing in the same therapeutic area as Cell MedX.
Sanofi
SNY
Mkt Cap104.54B
Sanofi S.A. engages in the development and marketing of therapeutic solutions including diabetes care, which competes with Cell MedX's market.
Merck
MRK
Mkt Cap293.22B
Merck & Co., Inc. provides healthcare solutions including diabetes management drugs and therapies, competing in the broader diabetes care market relevant to Cell MedX.

About

StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions in the United States. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Cell MedX Corp. and changed its name to StimCell Energetics Inc. in November 2024. StimCell Energetics Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. David M. Jeffs
Employees
1
Country
United States
ISIN
US15115X2062

Listings

OTC Link
US
STME

0 Comments

Share your thoughts

FAQ

What is Stimcell Energetics stock price today?▼
The current price of STME is $0.35 USD — it has increased by +20.31% in the past 24 hours. Watch Stimcell Energetics stock price performance more closely on the chart.
What is Stimcell Energetics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Stimcell Energetics stocks are traded under the ticker STME.
What is Stimcell Energetics market cap?▼
Today Stimcell Energetics has the market capitalization of 7.29M
When is the next Stimcell Energetics earnings date?▼
Stimcell Energetics is going to release the next earnings report on July 29, 2026.
What were Stimcell Energetics earnings last quarter?▼
STME earnings for the last quarter are 0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Stimcell Energetics revenue for the last year?▼
Stimcell Energetics revenue for the last year amounts to 0 USD.
What is Stimcell Energetics net income for the last year?▼
STME net income for the last year is -1.13M USD.
How many employees does Stimcell Energetics have?▼
As of June 07, 2026, the company has 1 employees.
In which sector is Stimcell Energetics located?▼
Stimcell Energetics operates in the Other sector.
When did Stimcell Energetics complete a stock split?▼
The last stock split for Stimcell Energetics was on November 05, 2024 with a ratio of 1:15.
Where is Stimcell Energetics headquartered?▼
Stimcell Energetics is headquartered in Vancouver, United States.